Qvin

Qvin is pioneering a novel approach to women's healthcare by leveraging menstrual blood as a source for critical health information, offering a non-invasive alternative to traditional laboratory blood tests. Recognizing the historical underrepresentation of women's health in scientific research, Qvin was founded by Dr. Sara Naseri and Søren Therkelsen in 2014 to address this gap and develop innovative solutions for an underserved population.

Considering that over 70% of medical decisions are informed by blood test results, and with 1.8 billion people menstruating globally each month, Qvin aims to unlock the potential of menstrual blood as a readily available and unexplored testing resource. By providing women with an accessible and insightful means to monitor existing health conditions, proactively screen for potential issues, and engage in more informed consultations with healthcare providers, Qvin empowers women to take control of their health.

At the core of Qvin's health technology platform is the Q-Pad™, a non-invasive blood collection device designed to facilitate convenient and reliable sample collection. Qvin is committed to advancing the study of women's health, bridging the gender data gap, and advocating for all individuals who identify as women.